MedDataX Logo

Intraoperative and Postoperative Analgesia for Laparoscopic Surgery.

NCT ID: NCT00772187

Last Updated: 2010-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-10-31

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Main Hypothesis: laparoscopic surgery is very painful to patient during and after surgery. We would like to compare different analgesic methods.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

General anesthesia + I.V pca

Group Type EXPERIMENTAL

general anesthesia (fentanyl)

Intervention Type DRUG

general anesthesia alone

2

General anesthesia + spinal analgesia + I.V pca

Group Type EXPERIMENTAL

morphine

Intervention Type DRUG

Single dose: 0.1-0.5 mg

intrathecal analgesia (morphine)

Intervention Type DRUG

0.1-0.5 mg of morphine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

morphine

Single dose: 0.1-0.5 mg

Intervention Type DRUG

intrathecal analgesia (morphine)

0.1-0.5 mg of morphine

Intervention Type DRUG

general anesthesia (fentanyl)

general anesthesia alone

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Laparoscopic (general) Surgery
* Age\>18
* ASA\<4
* Morning surgery

Exclusion Criteria

* Patient refusal
* contra-indication for treatment
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rambam Health Care Campus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rambam Health Care Campus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rambam Health Care Campus

Haifa, Israel, Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Rambam2690CTIL

Identifier Type: -

Identifier Source: org_study_id